BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28393715)

  • 1. Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages?
    Türk M; Yıldırım F; Yurdakul AS; Öztürk C
    Tuberk Toraks; 2016 Dec; 64(4):263-268. PubMed ID: 28393715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung cancer diagnosis: hospitalization costs].
    Arca JA; Ramos MA; de la Infanta RG; López CP; Pérez LG; López JL
    Arch Bronconeumol; 2006 Nov; 42(11):569-74. PubMed ID: 17125691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and costs of treating lung cancer patients in a university hospital.
    Dedes KJ; Szucs TD; Bodis S; Joerger M; Lowy A; Russi EW; Steinert HC; Weder W; Stahel RA
    Pharmacoeconomics; 2004; 22(7):435-44. PubMed ID: 15137882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic Value of Transbronchial Ultrasound-guided Needle Aspiration Biopsy in the Diagnosis of Small Cell Lung Cancer and Non-small Cell Lung Cancer].
    Tan X; Liu B; Wang R; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):466-471. PubMed ID: 32517451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease model.
    Buja A; Rivera M; De Polo A; Brino ED; Marchetti M; Scioni M; Pasello G; Bortolami A; Rebba V; Schiavon M; Calabrese F; Mandoliti G; Baldo V; Conte P
    Thorac Cancer; 2021 Jan; 12(1):13-20. PubMed ID: 33219738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain).
    Corral J; Espinàs JA; Cots F; Pareja L; Solà J; Font R; Borràs JM
    BMC Health Serv Res; 2015 Feb; 15():70. PubMed ID: 25889153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Cost Implications of Universal Versus Locally Advanced-Stage and Advanced-Stage-Only Molecular Testing for Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangements in Non-Small Cell Lung Carcinoma: A Tertiary Academic Institution Experience.
    Sauter JL; Butnor KJ
    Arch Pathol Lab Med; 2016 Apr; 140(4):358-61. PubMed ID: 27028394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobectomy for early-stage lung carcinoma: a cost analysis of full thoracoscopy versus posterolateral thoracotomy.
    Ramos R; Masuet C; Gossot D
    Surg Endosc; 2012 Feb; 26(2):431-7. PubMed ID: 21898011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer.
    Ihbe-Heffinger A; Paessens BJ; von Schilling C; Shlaen M; Gottschalk N; Berger K; Bernard R; Kiechle M; Peschel C; Jacobs VR
    Onkologie; 2011; 34(5):241-6. PubMed ID: 21577029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in practice patterns and costs between small cell and non-small cell lung cancer patients in Japan.
    Kuwabara K; Matsuda S; Fushimi K; Anan M; Ishikawa KB; Horiguchi H; Hayashida K; Fujimori K
    Tohoku J Exp Med; 2009 Jan; 217(1):29-35. PubMed ID: 19155605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing costs of metastatic non small cell lung cancer in the Netherlands.
    Keusters WR; de Weger VA; Hövels A; Schellens JHM; Frederix GWJ
    Lung Cancer; 2017 Dec; 114():56-61. PubMed ID: 29173766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of lung cancer management in South Western Sydney.
    Kang S; Koh ES; Vinod SK; Jalaludin B
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):235-41. PubMed ID: 22498199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
    Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA;
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
    Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
    Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
    Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
    Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y
    J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic Oncology Multidisciplinary Clinic Reduces Unnecessary Health Care Expenditure Used in the Workup of Patients With Non-small-cell Lung Cancer.
    Voong KR; Liang OS; Dugan P; Torto D; Padula WV; Senter JP; Lang M; Hooker CM; Feliciano J; Broderick S; Yarmus L; Khanna K; Narang A; Hales RK
    Clin Lung Cancer; 2019 Jul; 20(4):e430-e441. PubMed ID: 30956040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of non-small cell lung cancer in the Netherlands.
    van der Linden N; Bongers ML; Coupé VM; Smit EF; Groen HJ; Welling A; Schramel FM; Uyl-de Groot CA
    Lung Cancer; 2016 Jan; 91():79-88. PubMed ID: 26589654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalization Costs After Surgery in High-Risk Patients With Early Stage Lung Cancer.
    Sancheti MS; Chihara RK; Perez SD; Khullar OV; Fernandez FG; Pickens A; Force SD
    Ann Thorac Surg; 2018 Jan; 105(1):263-270. PubMed ID: 29174780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.